Lobbying

American Society of Cataract & Refractive Surgery's latest lobbying report covers Q2 2026, at $189.2K. The four quarters Q4 2025–Q3 2026 total $524K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.

American Society of Cataract & Refractive Surgery

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$524K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

American Society of Cataract & Refractive Surgery lobbying by quarter
American Society of Cataract & Refractive Surgery lobbying by quarter
QuarterAmountReports
Q4 2022$170.9K1
Q1 2023$143.9K1
Q2 2023$192.1K1
Q3 2023$148.5K1
Q4 2023$144.4K1
Q1 2024$123.7K1
Q2 2024$181.3K1
Q3 2024$98.1K1
Q4 2024$41K1
Q1 2025$166.7K1
Q2 2025$132.9K1
Q3 2025$167.8K1
Q4 2025$121.5K1
Q1 2026$213.3K1
Q2 2026$189.2K1
Q3 2026$00

By issue

  • Medicare and Medicaid$1.4M · 15 reports
  • Health issues$567.4K · 8 reports
  • Pharmacy$145.5K · 2 reports
  • Medical research and clinical labs$57K · 1 reports
  • Telecommunications$57K · 1 reports
  • Veterans$49.5K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Centers For Medicare and Medicaid Services (CMS)13 reports
  • Health & Human Services, Dept of (HHS)12 reports
  • Food & Drug Administration (FDA)4 reports
  • Labor, Dept of (DOL)2 reports
  • Treasury, Dept of2 reports
  • Education, Dept of1 reports
  • Homeland Security, Dept of (DHS)1 reports
  • Office of Management & Budget (OMB)1 reports
  • Veterans Affairs, Dept of (VA)1 reports

Firms it paid

Firm
In-houseAmerican Society of Cataract & Refractive Surgery$2.2M15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/08for Q2In-house$189.2K
05/04for Q1In-house$213.3K
01/07for Q4 2025In-house$121.5K
25/10/13for Q3 2025In-house$167.8K
25/07/18for Q2 2025In-house$132.9K
25/04/18for Q1 2025In-house$166.7K
25/01/21for Q4 2024In-house$41K
24/10/15for Q3 2024In-house$98.1K
24/07/17for Q2 2024In-house$181.3K
24/04/22for Q1 2024In-house$123.7K
24/01/19for Q4 2023In-house$144.4K
23/10/18for Q3 2023In-house$148.5K
23/07/20for Q2 2023In-house$192.1K
23/04/12for Q1 2023In-house$143.9K
23/01/19for Q4 2022In-house$170.9K